111 related articles for article (PubMed ID: 28476374)
1. Alterations of plasma concentrations of lipophilic antioxidants are associated with Guillain-Barre syndrome.
Tang HY; Ho HY; Chiu DT; Huang CY; Cheng ML; Chen CM
Clin Chim Acta; 2017 Jul; 470():75-80. PubMed ID: 28476374
[TBL] [Abstract][Full Text] [Related]
2. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
Ghabaee M; Jabedari B; Al-E-Eshagh N; Ghaffarpour M; Asadi F
Int J Neurosci; 2010 Apr; 120(4):301-4. PubMed ID: 20374079
[TBL] [Abstract][Full Text] [Related]
3. Free radical toxicity and antioxidants in Guillain-Barre syndrome, a preliminary study.
Kumar KT; Chandrika A; Sumanth KN; Sireesha P; Rao S; Rao A
Clin Chim Acta; 2004 Aug; 346(2):205-9. PubMed ID: 15256322
[TBL] [Abstract][Full Text] [Related]
4. Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome.
Tang HY; Chiu DT; Lin JF; Huang CY; Chang KH; Lyu RK; Ro LS; Kuo HC; Cheng ML; Chen CM
Sci Rep; 2017 Aug; 7(1):8140. PubMed ID: 28811529
[TBL] [Abstract][Full Text] [Related]
5. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol.
Kontush A; Spranger T; Reich A; Baum K; Beisiegel U
Atherosclerosis; 1999 May; 144(1):117-22. PubMed ID: 10381285
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
8. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré syndrome.
Li C; Zhao P; Sun X; Che Y; Jiang Y
Mediators Inflamm; 2013; 2013():639712. PubMed ID: 24174711
[TBL] [Abstract][Full Text] [Related]
10. Is serum bilirubin associated with the severity of Guillain-Barré syndrome?
Li X; Li W; Shi X; Mo L; Luo Y; Qin L; Yang Z; Mo W
Int J Neurosci; 2018 Jul; 128(7):595-599. PubMed ID: 29130362
[TBL] [Abstract][Full Text] [Related]
11. Comparison of plasma antioxidant levels and related metabolic parameters between smokers and non-smokers.
Chiu YW; Chuang HY; Huang MC; Wu MT; Liu HW; Huang CT
Kaohsiung J Med Sci; 2009 Aug; 25(8):423-30. PubMed ID: 19605336
[TBL] [Abstract][Full Text] [Related]
12. Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome.
Nakane S; Higuchi O; Hamada Y; Maeda Y; Mukaino A; Sakai W; Kusunoki S; Matsuo H
J Neuroimmunol; 2016 Jun; 295-296():54-9. PubMed ID: 27235349
[TBL] [Abstract][Full Text] [Related]
13. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease.
Himmelfarb J; Kane J; McMonagle E; Zaltas E; Bobzin S; Boddupalli S; Phinney S; Miller G
Kidney Int; 2003 Sep; 64(3):978-91. PubMed ID: 12911548
[TBL] [Abstract][Full Text] [Related]
14. Evidence for alterations in circulating low-molecular-weight antioxidants and increased lipid peroxidation in smokers on hemodialysis.
Lim PS; Wang NP; Lu TC; Wang TH; Hsu WM; Chan EC; Hung WR; Yang CC; Kuo IF; Wei YH
Nephron; 2001 Jun; 88(2):127-33. PubMed ID: 11399914
[TBL] [Abstract][Full Text] [Related]
15. Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barré syndrome.
Chang KH; Lyu RK; Ro YS; Chen YC; Ro LS; Chang HS; Huang CC; Liao MF; Wu YR; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2016 Oct; 461():8-13. PubMed ID: 27450064
[TBL] [Abstract][Full Text] [Related]
16. IL-35 Is Involved in the Pathogenesis of Guillain-Barré Syndrome Through Its Influence on the Function of CD4+ T Cells.
Liu H; Zhang W; Tian FF; Kun A; Zhou WB; Xiao B; Li J
Immunol Invest; 2015; 44(6):566-77. PubMed ID: 26225474
[TBL] [Abstract][Full Text] [Related]
17. Dynamic thiol-disulphide homeostasis in patients with Guillain-Barre Syndrome.
Gümüşyayla Ş; Vural G; Yurtoğulları Çevik Ş; Akdeniz G; Neselioğlu S; Deniz O; Erel Ö
Neurol Res; 2019 May; 41(5):413-418. PubMed ID: 30730791
[TBL] [Abstract][Full Text] [Related]
18. Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barré syndrome.
Liang SL; Wang WZ; Huang S; Wang XK; Zhang S; Wu Y
Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):1039-46. PubMed ID: 22738814
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome.
Kharwar NK; Prasad KN; Singh K; Paliwal VK; Modi DR
Int J Neurosci; 2017 Aug; 127(8):680-687. PubMed ID: 27595159
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits.
Chang CY; Chen JY; Ke D; Hu ML
Nutrition; 2005 Oct; 21(10):987-93. PubMed ID: 16157235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
